Barbour AP - Search Results

1

Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus.

Visser E, Edholm D, Smithers BM, Thomson IG, Burmeister BH, Walpole ET, Gotley DC, Joubert WL, Atkinson V, Mai T, Thomas JM, Barbour AP. Visser E, et al. Among authors: barbour ap. J Surg Oncol. 2018 Jun;117(8):1687-1696. doi: 10.1002/jso.25089. Epub 2018 May 28. J Surg Oncol. 2018. PMID: 29806960

2

Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3.

Barbour AP, Reeder JA, Walsh MD, Fawcett J, Antalis TM, Gotley DC. Barbour AP, et al. Cancer Res. 2003 Feb 15;63(4):887-92. Cancer Res. 2003. PMID: 12591743

3

Current concepts of tumour metastasis.

Barbour A, Gotley DC. Barbour A, et al. Ann Acad Med Singap. 2003 Mar;32(2):176-84. Ann Acad Med Singap. 2003. PMID: 12772520 Review.

4

Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.

Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF. Barbour AP, et al. Ann Surg Oncol. 2007 Feb;14(2):306-16. doi: 10.1245/s10434-006-9166-x. Epub 2006 Nov 8. Ann Surg Oncol. 2007. PMID: 17091329

5

Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy.

Smithers BM, Cullinan M, Thomas JM, Martin I, Barbour AP, Burmeister BH, Harvey JA, Thomson DB, Walpole ET, Gotley DC. Smithers BM, et al. Among authors: barbour ap. Dis Esophagus. 2007;20(6):471-7. doi: 10.1111/j.1442-2050.2007.00701.x. Dis Esophagus. 2007. PMID: 17958721

6

Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.

Barbour AP, Jones M, Gonen M, Gotley DC, Thomas J, Thomson DB, Burmeister B, Smithers BM. Barbour AP, et al. Ann Surg Oncol. 2008 Oct;15(10):2894-902. doi: 10.1245/s10434-008-0084-y. Epub 2008 Jul 29. Ann Surg Oncol. 2008. PMID: 18663531

7

Prognostic value of maximum standardized uptake values from preoperative positron emission tomography in resectable adenocarcinoma of the esophagus treated by surgery alone.

Shenfine J, Barbour AP, Wong D, Thomas J, Martin I, Gotley DC, Smithers BM. Shenfine J, et al. Among authors: barbour ap. Dis Esophagus. 2009;22(8):668-75. doi: 10.1111/j.1442-2050.2009.00941.x. Epub 2009 Feb 13. Dis Esophagus. 2009. PMID: 19222534

8

Isolated limb infusion for malignant melanoma: predictors of response and outcome.

Barbour AP, Thomas J, Suffolk J, Beller E, Smithers BM. Barbour AP, et al. Ann Surg Oncol. 2009 Dec;16(12):3463-72. doi: 10.1245/s10434-009-0717-9. Epub 2009 Oct 15. Ann Surg Oncol. 2009. PMID: 19830498

9

Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors.

Barbour AP, Jones M, Brown I, Gotley DC, Martin I, Thomas J, Clouston A, Smithers BM. Barbour AP, et al. Ann Surg Oncol. 2010 Sep;17(9):2494-502. doi: 10.1245/s10434-010-1025-0. Epub 2010 Mar 27. Ann Surg Oncol. 2010. PMID: 20349213

10

Thoracoscopic-assisted esophagectomy for esophageal cancer: analysis of patterns and prognostic factors for recurrence.

Thomson IG, Smithers BM, Gotley DC, Martin I, Thomas JM, O'Rourke P, Barbour AP. Thomson IG, et al. Among authors: barbour ap. Ann Surg. 2010 Aug;252(2):281-91. doi: 10.1097/SLA.0b013e3181e909a2. Ann Surg. 2010. PMID: 20647926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters